Amanda R. Pahng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amanda R. Pahng has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Angela E. Barattini
Department of Physiology, LSU Health Sciences Center, New Orleans, USA
4 shared publications- Kimberly N. Edwards
Department of Physiology, LSU Health Sciences Center, New Orleans, LA, United States; Alcohol & Drug Abuse Center of Excellence, LSU Health Sciences Center, New Orleans, LA, United States
2 shared publications - Nicholas Warren Gilpin
Department of Physiology, Louisiana State University Health Sciences Center
2 shared publications Scott Edwards
Department of Physiology, LSU Health Sciences Center, New Orleans, LA, United States; Alcohol & Drug Abuse Center of Excellence, LSU Health Sciences Center, New Orleans, LA, United States; Neuroscience Center of Excellence, LSU Health Sciences Center, New Orleans, LA, United States; Comprehensive Alcohol-HIV/AIDs Research Center, LSU Health Sciences Center, New Orleans, LA, United States
2 shared publicationsAlex Melain
Department of Physiology, LSU Health Sciences Center, New Orleans, LA, United States
1 shared publication- Chelsea N. Callicoatte
Department of Physiology, LSU Health Sciences Center, New Orleans, LA, United States
1 shared publication
Latest Publications
- 20 November 2024
- Published by Springer Nature in Psychopharmacology
- Vol. 242 (1) , 1-26
Interactions of pain and opioids on conditioned place preference in rodents
Rationale Opioid analgesics are the most effective medications used for the treatment of pain, however there are significant risks associated with repeated opioid use including opioid misuse and opioid use disorder development. Chronic pain affects millions of adults in the United States, and opioid misuse is often comorbid with pain conditions in individuals who are repeatedly treated with opioids. In addition to providing pain relief, opioids produce rewarding effects, but in chronic pain states, reward processing can become dysregulated. The conditioned place preference task is commonly used to measure the rewarding properties of opioids in rodents. During this task, opioid administration is paired with a distinct environment through repeated conditioning and the change in an animal’s preference for the paired environment indicates whether the opioid is rewarding or not. Objectives Rodent pain models can be combined with conditioned place preference to examine the effects of pain on opioid reward. The existing preclinical literature on pain effects on conditioned place preference is conflicting, where pain conditions have been reported to enhance, suppress, or have no effect on opioid reward. This review will discuss several factors that may contribute to these discordant findings including conditioning session duration and number, rodent strain differences in opioid sensitivity, analgesic properties of opioids at tested doses, locomotor effects at tested doses, and diurnal variation in pain sensitivity. Future studies should consider how these factors contribute to opioid conditioned place preference in both pain and pain-free animals to have a better understanding of the interactions between pain and opioid reward.
- 20 November 2024
- Published by Springer Nature in Psychopharmacology
- Vol. 242 (1) , 1-26
Interactions of pain and opioids on conditioned place preference in rodents
Rationale Opioid analgesics are the most effective medications used for the treatment of pain, however there are significant risks associated with repeated opioid use including opioid misuse and opioid use disorder development. Chronic pain affects millions of adults in the United States, and opioid misuse is often comorbid with pain conditions in individuals who are repeatedly treated with opioids. In addition to providing pain relief, opioids produce rewarding effects, but in chronic pain states, reward processing can become dysregulated. The conditioned place preference task is commonly used to measure the rewarding properties of opioids in rodents. During this task, opioid administration is paired with a distinct environment through repeated conditioning and the change in an animal’s preference for the paired environment indicates whether the opioid is rewarding or not. Objectives Rodent pain models can be combined with conditioned place preference to examine the effects of pain on opioid reward. The existing preclinical literature on pain effects on conditioned place preference is conflicting, where pain conditions have been reported to enhance, suppress, or have no effect on opioid reward. This review will discuss several factors that may contribute to these discordant findings including conditioning session duration and number, rodent strain differences in opioid sensitivity, analgesic properties of opioids at tested doses, locomotor effects at tested doses, and diurnal variation in pain sensitivity. Future studies should consider how these factors contribute to opioid conditioned place preference in both pain and pain-free animals to have a better understanding of the interactions between pain and opioid reward.
- 21 March 2023
- Published by Elsevier in Neuropharmacology
- Vol. 231, 109512
Chronic inflammatory pain promotes place preference for fentanyl in male rats but does not change fentanyl self-administration in male and female rats
- 21 March 2023
- Published by Elsevier in Neuropharmacology
- Vol. 231, 109512
Chronic inflammatory pain promotes place preference for fentanyl in male rats but does not change fentanyl self-administration in male and female rats
- 24 January 2022
- Published by Elsevier in Neuropharmacology
- Vol. 208, 108976
Pramipexole treatment attenuates mechanical hypersensitivity in male rats experiencing chronic inflammatory pain
- 24 January 2022
- Published by Elsevier in Neuropharmacology
- Vol. 208, 108976
Pramipexole treatment attenuates mechanical hypersensitivity in male rats experiencing chronic inflammatory pain
- 1 February 2017
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 117 (2) , 477-479
Pathophysiology of affective disorders: functional interaction of stress hormones and hippocampal excitation
An important new study by Kvarta, Bradbrook, Dantrassy, Bailey, and Thompson (J Neurophysiol 114: 1713–1724, 2015) examined the effects of persistent stress and excessive glucocorticoid levels on hippocampal function and emotional behavior in rodents. The authors specifically implicate the temporoammonic pathway as being susceptible to reductions in excitatory function in the context of chronic stress. We discuss the importance of this new finding in the broader context of medication development for major depressive disorder.
- 1 February 2017
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 117 (2) , 477-479
Pathophysiology of affective disorders: functional interaction of stress hormones and hippocampal excitation
An important new study by Kvarta, Bradbrook, Dantrassy, Bailey, and Thompson (J Neurophysiol 114: 1713–1724, 2015) examined the effects of persistent stress and excessive glucocorticoid levels on hippocampal function and emotional behavior in rodents. The authors specifically implicate the temporoammonic pathway as being susceptible to reductions in excitatory function in the context of chronic stress. We discuss the importance of this new finding in the broader context of medication development for major depressive disorder.